| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optic Neuropathy, Ischemic | 15 | 2024 | 86 | 4.360 |
Why?
|
| Visual Prosthesis | 9 | 2021 | 48 | 2.930 |
Why?
|
| Electric Stimulation | 24 | 2011 | 1734 | 2.880 |
Why?
|
| Retinal Ganglion Cells | 23 | 2023 | 810 | 2.580 |
Why?
|
| Blindness | 22 | 2023 | 585 | 2.400 |
Why?
|
| Retina | 27 | 2020 | 2655 | 2.330 |
Why?
|
| Electrodes, Implanted | 15 | 2020 | 838 | 2.060 |
Why?
|
| Giant Cell Arteritis | 7 | 2021 | 306 | 1.970 |
Why?
|
| Retinal Artery Occlusion | 7 | 2021 | 77 | 1.970 |
Why?
|
| Optic Neuritis | 12 | 2017 | 174 | 1.950 |
Why?
|
| Vision Disorders | 22 | 2023 | 1088 | 1.600 |
Why?
|
| Optic Nerve Diseases | 17 | 2023 | 342 | 1.560 |
Why?
|
| Retinal Diseases | 12 | 2024 | 704 | 1.290 |
Why?
|
| Blepharoptosis | 2 | 2023 | 144 | 1.160 |
Why?
|
| Microelectrodes | 14 | 2020 | 306 | 1.160 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 2 | 2017 | 8 | 1.150 |
Why?
|
| Action Potentials | 12 | 2011 | 1825 | 1.070 |
Why?
|
| Optic Disk | 14 | 2020 | 421 | 1.060 |
Why?
|
| Intracranial Hypertension | 4 | 2021 | 193 | 1.020 |
Why?
|
| Prosthesis Implantation | 8 | 2011 | 591 | 1.010 |
Why?
|
| Retinitis Pigmentosa | 5 | 2012 | 397 | 0.940 |
Why?
|
| Ophthalmic Artery | 3 | 2021 | 58 | 0.920 |
Why?
|
| Retinal Artery | 3 | 2021 | 109 | 0.910 |
Why?
|
| Vision, Ocular | 10 | 2021 | 454 | 0.910 |
Why?
|
| Temporal Arteries | 5 | 2015 | 154 | 0.910 |
Why?
|
| Ophthalmoplegia | 3 | 2023 | 168 | 0.880 |
Why?
|
| Sensory Thresholds | 7 | 2009 | 377 | 0.870 |
Why?
|
| Ocular Motility Disorders | 4 | 2017 | 144 | 0.860 |
Why?
|
| Tomography, Optical Coherence | 9 | 2024 | 2917 | 0.840 |
Why?
|
| Glucagon-Like Peptides | 1 | 2024 | 153 | 0.840 |
Why?
|
| Orbital Neoplasms | 4 | 2022 | 222 | 0.830 |
Why?
|
| Visual Fields | 19 | 2018 | 1062 | 0.810 |
Why?
|
| Optic Nerve | 11 | 2023 | 572 | 0.800 |
Why?
|
| Electric Stimulation Therapy | 6 | 2011 | 626 | 0.760 |
Why?
|
| Evoked Potentials, Visual | 9 | 2009 | 417 | 0.750 |
Why?
|
| Eye Neoplasms | 2 | 2022 | 307 | 0.750 |
Why?
|
| Adnexal Diseases | 1 | 2022 | 104 | 0.740 |
Why?
|
| Orbit | 2 | 2024 | 457 | 0.740 |
Why?
|
| Neurofibromatosis 1 | 2 | 2024 | 560 | 0.730 |
Why?
|
| Eye, Artificial | 2 | 2012 | 18 | 0.720 |
Why?
|
| Sex Reassignment Procedures | 1 | 2021 | 70 | 0.710 |
Why?
|
| Scotoma | 4 | 2017 | 130 | 0.680 |
Why?
|
| Retinal Vessels | 5 | 2021 | 853 | 0.670 |
Why?
|
| Vision, Monocular | 2 | 2017 | 71 | 0.670 |
Why?
|
| Intracranial Embolism | 1 | 2021 | 187 | 0.660 |
Why?
|
| Telemetry | 2 | 2011 | 199 | 0.640 |
Why?
|
| Intracranial Pressure | 1 | 2021 | 324 | 0.640 |
Why?
|
| Electroretinography | 15 | 2009 | 524 | 0.630 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 2 | 2017 | 50 | 0.630 |
Why?
|
| Prostheses and Implants | 7 | 2009 | 1269 | 0.620 |
Why?
|
| Coated Materials, Biocompatible | 4 | 2009 | 311 | 0.610 |
Why?
|
| Prosthesis Design | 7 | 2012 | 2114 | 0.600 |
Why?
|
| Diplopia | 4 | 2013 | 214 | 0.600 |
Why?
|
| Isaacs Syndrome | 1 | 2017 | 5 | 0.600 |
Why?
|
| Visual Acuity | 21 | 2021 | 2676 | 0.590 |
Why?
|
| Pseudotumor Cerebri | 2 | 2017 | 108 | 0.590 |
Why?
|
| Embolism | 1 | 2021 | 399 | 0.580 |
Why?
|
| Eye Diseases | 7 | 2004 | 653 | 0.570 |
Why?
|
| Deglutition Disorders | 1 | 2023 | 627 | 0.570 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 702 | 0.570 |
Why?
|
| Abducens Nerve Diseases | 1 | 2017 | 44 | 0.560 |
Why?
|
| Exotropia | 1 | 2017 | 64 | 0.550 |
Why?
|
| Hypotension | 1 | 2023 | 879 | 0.550 |
Why?
|
| GTP Phosphohydrolases | 2 | 2017 | 517 | 0.540 |
Why?
|
| Multiple Sclerosis | 5 | 2023 | 3222 | 0.540 |
Why?
|
| Choroid | 4 | 2024 | 360 | 0.530 |
Why?
|
| Videotape Recording | 1 | 2017 | 338 | 0.520 |
Why?
|
| Rabbits | 18 | 2011 | 4770 | 0.510 |
Why?
|
| Papilledema | 5 | 2010 | 130 | 0.490 |
Why?
|
| Choroidal Neovascularization | 1 | 2017 | 363 | 0.440 |
Why?
|
| Pituitary Gland | 1 | 2016 | 635 | 0.440 |
Why?
|
| Vision Tests | 4 | 2010 | 161 | 0.440 |
Why?
|
| Iridium | 2 | 2011 | 30 | 0.430 |
Why?
|
| Horner Syndrome | 1 | 2013 | 35 | 0.420 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2019 | 738 | 0.420 |
Why?
|
| Subclavian Artery | 1 | 2013 | 133 | 0.400 |
Why?
|
| Differential Threshold | 2 | 2011 | 80 | 0.400 |
Why?
|
| Internationality | 2 | 2016 | 1000 | 0.390 |
Why?
|
| Visual Perception | 8 | 2016 | 1388 | 0.390 |
Why?
|
| Oculomotor Muscles | 4 | 2010 | 406 | 0.390 |
Why?
|
| Psychological Tests | 1 | 2014 | 639 | 0.380 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 3085 | 0.380 |
Why?
|
| Nervous System Diseases | 5 | 2004 | 1662 | 0.380 |
Why?
|
| Headache | 3 | 2018 | 1255 | 0.370 |
Why?
|
| GABA Antagonists | 1 | 2011 | 119 | 0.370 |
Why?
|
| Humans | 141 | 2024 | 760740 | 0.370 |
Why?
|
| Ciliary Arteries | 2 | 2021 | 19 | 0.370 |
Why?
|
| Biomedical Engineering | 2 | 2009 | 286 | 0.370 |
Why?
|
| Swine, Miniature | 4 | 2020 | 961 | 0.360 |
Why?
|
| Fluorescein Angiography | 7 | 2017 | 1060 | 0.350 |
Why?
|
| Orbital Myositis | 2 | 2020 | 25 | 0.340 |
Why?
|
| Aneurysm | 1 | 2013 | 337 | 0.340 |
Why?
|
| Advisory Committees | 1 | 2014 | 787 | 0.330 |
Why?
|
| Cluster Headache | 2 | 2020 | 54 | 0.330 |
Why?
|
| Nystagmus, Pathologic | 1 | 2010 | 105 | 0.330 |
Why?
|
| Awards and Prizes | 1 | 2013 | 360 | 0.330 |
Why?
|
| Materials Testing | 3 | 2009 | 863 | 0.320 |
Why?
|
| Implants, Experimental | 1 | 2009 | 99 | 0.320 |
Why?
|
| Microtechnology | 1 | 2009 | 70 | 0.320 |
Why?
|
| Eye Movements | 3 | 2010 | 511 | 0.320 |
Why?
|
| Neuromuscular Agents | 1 | 2010 | 148 | 0.310 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2009 | 122 | 0.310 |
Why?
|
| Arteritis | 3 | 2019 | 158 | 0.310 |
Why?
|
| Photic Stimulation | 7 | 2009 | 1987 | 0.310 |
Why?
|
| Ophthalmology | 2 | 2013 | 550 | 0.300 |
Why?
|
| Glucocorticoids | 7 | 2018 | 2160 | 0.300 |
Why?
|
| Ischemia | 4 | 2021 | 1885 | 0.280 |
Why?
|
| Animals | 39 | 2024 | 168202 | 0.280 |
Why?
|
| Sodium Channels | 1 | 2009 | 339 | 0.280 |
Why?
|
| Visual Pathways | 5 | 2009 | 551 | 0.280 |
Why?
|
| Neuromyelitis Optica | 3 | 2017 | 264 | 0.280 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2010 | 238 | 0.270 |
Why?
|
| Axons | 5 | 2012 | 1671 | 0.270 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2024 | 664 | 0.250 |
Why?
|
| Neurology | 1 | 2013 | 784 | 0.250 |
Why?
|
| Retinal Vein Occlusion | 2 | 1999 | 149 | 0.250 |
Why?
|
| Swine | 5 | 2020 | 5908 | 0.250 |
Why?
|
| Electrodes | 4 | 2011 | 610 | 0.250 |
Why?
|
| Nerve Net | 2 | 2008 | 2290 | 0.250 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 602 | 0.240 |
Why?
|
| Paraneoplastic Syndromes | 3 | 1997 | 155 | 0.230 |
Why?
|
| Biological Clocks | 1 | 2007 | 318 | 0.230 |
Why?
|
| Strabismus | 3 | 2010 | 317 | 0.230 |
Why?
|
| Device Removal | 1 | 2009 | 629 | 0.230 |
Why?
|
| Reaction Time | 3 | 2006 | 2087 | 0.230 |
Why?
|
| Retinaldehyde | 1 | 2003 | 24 | 0.230 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 564 | 0.230 |
Why?
|
| Retinal Degeneration | 2 | 2008 | 414 | 0.230 |
Why?
|
| Diagnosis, Differential | 14 | 2020 | 12966 | 0.230 |
Why?
|
| Biocompatible Materials | 3 | 2007 | 1683 | 0.220 |
Why?
|
| Hyperoxaluria | 1 | 2023 | 32 | 0.220 |
Why?
|
| Blood Patch, Epidural | 1 | 2003 | 57 | 0.220 |
Why?
|
| Semiconductors | 1 | 2004 | 99 | 0.220 |
Why?
|
| Chronotherapy | 1 | 2023 | 11 | 0.220 |
Why?
|
| Mitochondria | 1 | 2016 | 3619 | 0.210 |
Why?
|
| Visual Field Tests | 5 | 2017 | 411 | 0.210 |
Why?
|
| Calcium Oxalate | 1 | 2023 | 75 | 0.210 |
Why?
|
| Sneezing | 1 | 2002 | 17 | 0.210 |
Why?
|
| Membrane Potentials | 2 | 2005 | 1089 | 0.200 |
Why?
|
| Spinal Puncture | 3 | 2018 | 282 | 0.200 |
Why?
|
| Recovery of Function | 3 | 2018 | 2977 | 0.200 |
Why?
|
| Trochlear Nerve Diseases | 1 | 2002 | 15 | 0.200 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2948 | 0.200 |
Why?
|
| Models, Neurological | 3 | 2010 | 1768 | 0.200 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2021 | 1431 | 0.200 |
Why?
|
| Pupil Disorders | 1 | 2002 | 33 | 0.200 |
Why?
|
| Occipital Lobe | 1 | 2004 | 374 | 0.200 |
Why?
|
| Carotid Artery, Internal | 3 | 2021 | 445 | 0.190 |
Why?
|
| Acetazolamide | 2 | 2017 | 96 | 0.190 |
Why?
|
| Female | 67 | 2024 | 392203 | 0.190 |
Why?
|
| Tissue Engineering | 2 | 2009 | 1865 | 0.190 |
Why?
|
| Fundus Oculi | 8 | 2017 | 556 | 0.190 |
Why?
|
| Aged | 44 | 2024 | 169092 | 0.190 |
Why?
|
| Optic Nerve Neoplasms | 3 | 2009 | 45 | 0.180 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2023 | 244 | 0.180 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 1169 | 0.180 |
Why?
|
| Nervous System Neoplasms | 1 | 2001 | 91 | 0.180 |
Why?
|
| Male | 63 | 2024 | 360402 | 0.180 |
Why?
|
| Intracranial Aneurysm | 2 | 2004 | 1285 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 12143 | 0.170 |
Why?
|
| Biopsy | 5 | 2016 | 6763 | 0.170 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2015 | 2789 | 0.170 |
Why?
|
| Central Nervous System | 1 | 2007 | 1333 | 0.170 |
Why?
|
| Intraocular Pressure | 4 | 2021 | 1294 | 0.170 |
Why?
|
| Autopsy | 1 | 2023 | 1008 | 0.170 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2000 | 354 | 0.170 |
Why?
|
| Middle Aged | 50 | 2024 | 220603 | 0.170 |
Why?
|
| Optic Nerve Injuries | 3 | 1999 | 150 | 0.160 |
Why?
|
| Light | 3 | 2007 | 1352 | 0.160 |
Why?
|
| Ocular Hypertension | 1 | 2020 | 209 | 0.160 |
Why?
|
| Adult | 54 | 2024 | 220995 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2023 | 36401 | 0.150 |
Why?
|
| Retrospective Studies | 15 | 2024 | 80583 | 0.150 |
Why?
|
| Optic Disk Drusen | 1 | 2017 | 38 | 0.140 |
Why?
|
| Subretinal Fluid | 1 | 2017 | 24 | 0.140 |
Why?
|
| Reading | 1 | 2021 | 531 | 0.140 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2017 | 91 | 0.140 |
Why?
|
| PC12 Cells | 2 | 2007 | 317 | 0.140 |
Why?
|
| Autoimmune Diseases | 2 | 2024 | 2238 | 0.140 |
Why?
|
| Hemianopsia | 1 | 2018 | 121 | 0.140 |
Why?
|
| Vision, Low | 2 | 2008 | 163 | 0.130 |
Why?
|
| Aging | 7 | 2023 | 8700 | 0.130 |
Why?
|
| Neural Prostheses | 1 | 2016 | 22 | 0.130 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2016 | 93 | 0.130 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2019 | 410 | 0.130 |
Why?
|
| Visual Cortex | 3 | 2006 | 1105 | 0.130 |
Why?
|
| Neurosyphilis | 1 | 2016 | 27 | 0.130 |
Why?
|
| MELAS Syndrome | 1 | 2016 | 56 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 3356 | 0.130 |
Why?
|
| Neurites | 2 | 2009 | 391 | 0.130 |
Why?
|
| Susac Syndrome | 1 | 2015 | 22 | 0.130 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2016 | 50 | 0.130 |
Why?
|
| Intravitreal Injections | 1 | 2017 | 385 | 0.120 |
Why?
|
| Equipment Failure Analysis | 2 | 2009 | 843 | 0.120 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 1995 | 27 | 0.120 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 153 | 0.120 |
Why?
|
| Glaucoma | 2 | 2021 | 1186 | 0.120 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2008 | 446 | 0.120 |
Why?
|
| Blood Vessels | 1 | 2020 | 1112 | 0.120 |
Why?
|
| Perceptual Disorders | 1 | 2016 | 198 | 0.120 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 2575 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 495 | 0.120 |
Why?
|
| Neurons | 3 | 2009 | 9436 | 0.120 |
Why?
|
| Endoscopy | 1 | 2024 | 1851 | 0.120 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 582 | 0.110 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 1995 | 118 | 0.110 |
Why?
|
| Acute Disease | 5 | 2017 | 7236 | 0.110 |
Why?
|
| DNA, Mitochondrial | 2 | 2017 | 865 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2018 | 0.110 |
Why?
|
| Infarction | 1 | 1994 | 248 | 0.110 |
Why?
|
| Injections, Intramuscular | 2 | 2010 | 555 | 0.100 |
Why?
|
| Angiography | 1 | 2018 | 1595 | 0.100 |
Why?
|
| Cells, Cultured | 4 | 2011 | 18937 | 0.100 |
Why?
|
| Meningioma | 3 | 2009 | 1215 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 3 | 2003 | 1474 | 0.100 |
Why?
|
| Electrophysiology | 4 | 2010 | 1262 | 0.100 |
Why?
|
| Meningeal Neoplasms | 3 | 2009 | 1245 | 0.100 |
Why?
|
| Melatonin | 3 | 2002 | 669 | 0.100 |
Why?
|
| Fourier Analysis | 1 | 2012 | 440 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2015 | 1878 | 0.090 |
Why?
|
| Blood Flow Velocity | 3 | 2004 | 1369 | 0.090 |
Why?
|
| New York | 1 | 2013 | 875 | 0.090 |
Why?
|
| Amblyopia | 1 | 1993 | 152 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2017 | 2048 | 0.090 |
Why?
|
| Retinal Vasculitis | 1 | 2011 | 46 | 0.090 |
Why?
|
| Equipment Design | 2 | 2009 | 3501 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2016 | 802 | 0.090 |
Why?
|
| Ophthalmoscopes | 1 | 2010 | 20 | 0.090 |
Why?
|
| Histocytochemistry | 1 | 2011 | 696 | 0.090 |
Why?
|
| Young Adult | 7 | 2021 | 59191 | 0.090 |
Why?
|
| Sarcoidosis | 1 | 2016 | 520 | 0.090 |
Why?
|
| Retinal Neurons | 1 | 2010 | 67 | 0.090 |
Why?
|
| Vitrectomy | 2 | 2004 | 392 | 0.090 |
Why?
|
| Circadian Rhythm | 4 | 2007 | 2569 | 0.090 |
Why?
|
| Capillaries | 3 | 2020 | 756 | 0.080 |
Why?
|
| Electrochemistry | 1 | 2009 | 145 | 0.080 |
Why?
|
| Radioisotopes | 1 | 2010 | 499 | 0.080 |
Why?
|
| Telecommunications | 1 | 2009 | 79 | 0.080 |
Why?
|
| Ethambutol | 1 | 2008 | 59 | 0.080 |
Why?
|
| Ankyrins | 1 | 2009 | 123 | 0.080 |
Why?
|
| Carotid Artery Diseases | 1 | 1995 | 877 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2358 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2137 | 0.080 |
Why?
|
| Polylysine | 1 | 2009 | 131 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 1995 | 1988 | 0.080 |
Why?
|
| Boston | 2 | 2012 | 9313 | 0.080 |
Why?
|
| Eye Movement Measurements | 1 | 2008 | 31 | 0.080 |
Why?
|
| Artifacts | 2 | 2011 | 1910 | 0.080 |
Why?
|
| Rats | 3 | 2011 | 23716 | 0.070 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2007 | 31 | 0.070 |
Why?
|
| Conjunctiva | 1 | 2011 | 479 | 0.070 |
Why?
|
| Reflex, Pupillary | 1 | 2007 | 62 | 0.070 |
Why?
|
| Biophysics | 1 | 2009 | 379 | 0.070 |
Why?
|
| Incidence | 2 | 2024 | 21339 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2013 | 1566 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2021 | 3030 | 0.070 |
Why?
|
| Collagen | 2 | 2021 | 2634 | 0.070 |
Why?
|
| Laurence-Moon Syndrome | 1 | 1986 | 9 | 0.070 |
Why?
|
| Mutation | 5 | 2017 | 30015 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2017 | 2048 | 0.070 |
Why?
|
| Motion Perception | 2 | 2009 | 374 | 0.070 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 913 | 0.070 |
Why?
|
| Nerve Fibers | 2 | 2017 | 707 | 0.070 |
Why?
|
| Electromyography | 2 | 2010 | 1392 | 0.070 |
Why?
|
| Visually Impaired Persons | 1 | 2007 | 78 | 0.070 |
Why?
|
| Risk Factors | 3 | 2024 | 74128 | 0.070 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2006 | 57 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2009 | 20077 | 0.070 |
Why?
|
| Anesthetics, Local | 2 | 2004 | 997 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 925 | 0.070 |
Why?
|
| Spasm | 1 | 1986 | 130 | 0.070 |
Why?
|
| Lactates | 1 | 2007 | 404 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 3492 | 0.070 |
Why?
|
| Surface Properties | 1 | 2009 | 1162 | 0.070 |
Why?
|
| Optic Atrophy | 1 | 1986 | 79 | 0.070 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 142 | 0.070 |
Why?
|
| Genetic Testing | 2 | 2017 | 3533 | 0.070 |
Why?
|
| Prospective Studies | 6 | 2023 | 54364 | 0.070 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2006 | 209 | 0.060 |
Why?
|
| Eye Injuries | 1 | 2009 | 227 | 0.060 |
Why?
|
| Dysautonomia, Familial | 1 | 1986 | 94 | 0.060 |
Why?
|
| Radiotherapy, Conformal | 1 | 2009 | 548 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2013 | 2764 | 0.060 |
Why?
|
| Homeostasis | 1 | 2016 | 3321 | 0.060 |
Why?
|
| Gadolinium | 1 | 2010 | 959 | 0.060 |
Why?
|
| Gold | 1 | 2009 | 481 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2018 | 2152 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 944 | 0.060 |
Why?
|
| Blast Injuries | 1 | 2009 | 322 | 0.060 |
Why?
|
| Lacrimal Apparatus | 1 | 1987 | 223 | 0.060 |
Why?
|
| Radiography | 2 | 2012 | 6961 | 0.060 |
Why?
|
| Beak | 1 | 2024 | 10 | 0.060 |
Why?
|
| Mice | 5 | 2023 | 81368 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2019 | 9310 | 0.060 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2006 | 246 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2015 | 3998 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2009 | 5239 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2005 | 405 | 0.060 |
Why?
|
| Macular Degeneration | 1 | 2012 | 1008 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2006 | 296 | 0.060 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2004 | 239 | 0.060 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 498 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 1202 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2009 | 2669 | 0.060 |
Why?
|
| Blood Circulation | 1 | 2004 | 248 | 0.050 |
Why?
|
| Calcium | 1 | 2016 | 5717 | 0.050 |
Why?
|
| Awareness | 1 | 2007 | 649 | 0.050 |
Why?
|
| Foreign-Body Reaction | 1 | 2004 | 157 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 2063 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 4172 | 0.050 |
Why?
|
| Nervous System | 1 | 1986 | 545 | 0.050 |
Why?
|
| Quality of Life | 3 | 2021 | 13359 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22153 | 0.050 |
Why?
|
| Needlestick Injuries | 1 | 2003 | 71 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 796 | 0.050 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2005 | 266 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 245 | 0.050 |
Why?
|
| Orientation | 1 | 2004 | 321 | 0.050 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2002 | 53 | 0.050 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2004 | 880 | 0.050 |
Why?
|
| Injections, Epidural | 1 | 2003 | 201 | 0.050 |
Why?
|
| Computer-Aided Design | 1 | 2004 | 298 | 0.050 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1987 | 491 | 0.050 |
Why?
|
| Microscopy, Polarization | 1 | 2021 | 88 | 0.050 |
Why?
|
| Carcinoma | 1 | 2013 | 2328 | 0.050 |
Why?
|
| Hydrogels | 1 | 2007 | 720 | 0.050 |
Why?
|
| Phacoemulsification | 1 | 2003 | 149 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 1182 | 0.050 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2003 | 124 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2003 | 957 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 232 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 1496 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2007 | 7995 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2020 | 51 | 0.050 |
Why?
|
| Aged, 80 and over | 13 | 2016 | 58919 | 0.040 |
Why?
|
| Apoptosis | 1 | 2016 | 9476 | 0.040 |
Why?
|
| Pattern Recognition, Visual | 5 | 2008 | 824 | 0.040 |
Why?
|
| Eye Burns | 1 | 2000 | 65 | 0.040 |
Why?
|
| Polycythemia Vera | 1 | 2002 | 161 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 1987 | 1161 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 22117 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2008 | 1375 | 0.040 |
Why?
|
| Injections | 1 | 2003 | 832 | 0.040 |
Why?
|
| Foreign Bodies | 1 | 2024 | 402 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 8165 | 0.040 |
Why?
|
| Neuronal Plasticity | 2 | 2007 | 1433 | 0.040 |
Why?
|
| Computer Simulation | 3 | 2010 | 6233 | 0.040 |
Why?
|
| Military Personnel | 1 | 2009 | 1245 | 0.040 |
Why?
|
| Radiation Injuries | 1 | 1986 | 1189 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2020 | 428 | 0.040 |
Why?
|
| Artificial Organs | 1 | 2000 | 150 | 0.040 |
Why?
|
| Models, Biological | 2 | 2011 | 9461 | 0.040 |
Why?
|
| Time Factors | 5 | 2006 | 39908 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1056 | 0.040 |
Why?
|
| Aneurysm, Ruptured | 1 | 2004 | 464 | 0.040 |
Why?
|
| Alzheimer Disease | 4 | 1994 | 8603 | 0.040 |
Why?
|
| Wounds, Nonpenetrating | 3 | 1999 | 806 | 0.040 |
Why?
|
| Cataract Extraction | 1 | 2002 | 467 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2000 | 794 | 0.040 |
Why?
|
| Adolescent | 14 | 2006 | 88247 | 0.040 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 39062 | 0.040 |
Why?
|
| Postoperative Complications | 3 | 2006 | 15609 | 0.040 |
Why?
|
| Albendazole | 1 | 1997 | 50 | 0.040 |
Why?
|
| Photography | 3 | 1997 | 532 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2009 | 2053 | 0.030 |
Why?
|
| Color Perception | 3 | 1994 | 213 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2003 | 781 | 0.030 |
Why?
|
| Myasthenia Gravis | 1 | 1999 | 214 | 0.030 |
Why?
|
| Thailand | 1 | 2017 | 287 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2017 | 384 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 1674 | 0.030 |
Why?
|
| Age Distribution | 1 | 2002 | 2872 | 0.030 |
Why?
|
| Cryptococcosis | 1 | 1997 | 103 | 0.030 |
Why?
|
| Smoking | 1 | 1993 | 9054 | 0.030 |
Why?
|
| Spinal Fusion | 1 | 2006 | 1275 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2010 | 26065 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 1996 | 91 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1999 | 543 | 0.030 |
Why?
|
| Syndrome | 3 | 2003 | 3268 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2005 | 3680 | 0.030 |
Why?
|
| Pregnancy | 2 | 2016 | 29869 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 14649 | 0.030 |
Why?
|
| Patient Selection | 1 | 2007 | 4237 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2024 | 1589 | 0.030 |
Why?
|
| Glioma | 2 | 2001 | 3452 | 0.030 |
Why?
|
| Candidiasis | 1 | 1997 | 365 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 1718 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2004 | 1418 | 0.030 |
Why?
|
| Brain | 4 | 2016 | 27100 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2003 | 1546 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2000 | 1397 | 0.030 |
Why?
|
| Cerebral Arteries | 1 | 1996 | 490 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4110 | 0.030 |
Why?
|
| Hydroxocobalamin | 1 | 1993 | 27 | 0.030 |
Why?
|
| Lasers | 2 | 2003 | 952 | 0.030 |
Why?
|
| Nerve Compression Syndromes | 1 | 1995 | 160 | 0.030 |
Why?
|
| Decision Making | 1 | 2007 | 3919 | 0.030 |
Why?
|
| Genital Diseases, Female | 1 | 1994 | 192 | 0.030 |
Why?
|
| Choroid Diseases | 1 | 1993 | 63 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2008 | 14388 | 0.030 |
Why?
|
| Infant | 2 | 2008 | 36157 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 1999 | 1265 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 1997 | 753 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1835 | 0.020 |
Why?
|
| Eye | 1 | 2016 | 713 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2008 | 42193 | 0.020 |
Why?
|
| Child | 5 | 2009 | 80089 | 0.020 |
Why?
|
| Photoreceptor Cells | 1 | 1992 | 235 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4408 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1999 | 1695 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 5430 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 2016 | 937 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 20556 | 0.020 |
Why?
|
| Paclitaxel | 1 | 1998 | 1730 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 3117 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 1994 | 653 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2002 | 12333 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 1992 | 420 | 0.020 |
Why?
|
| Glaucoma, Neovascular | 1 | 1990 | 37 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 15250 | 0.020 |
Why?
|
| Pelvis | 1 | 1994 | 732 | 0.020 |
Why?
|
| Age Factors | 4 | 2008 | 18381 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 3527 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 1995 | 1281 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 1703 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1992 | 850 | 0.020 |
Why?
|
| Oxygen | 1 | 2020 | 4226 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18220 | 0.020 |
Why?
|
| Cavernous Sinus | 1 | 1990 | 123 | 0.020 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2008 | 76 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2010 | 64572 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2020 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2004 | 6635 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 2570 | 0.020 |
Why?
|
| Autoantigens | 1 | 1992 | 888 | 0.020 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 1987 | 23 | 0.020 |
Why?
|
| Electrooculography | 1 | 2007 | 113 | 0.020 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 1990 | 190 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 5776 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2008 | 203 | 0.020 |
Why?
|
| Recurrence | 2 | 2015 | 8426 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1990 | 319 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4739 | 0.020 |
Why?
|
| Prognosis | 4 | 2008 | 29601 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 1986 | 171 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 20988 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2011 | 819 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 1995 | 1081 | 0.020 |
Why?
|
| Photons | 1 | 2009 | 589 | 0.020 |
Why?
|
| United States | 4 | 2017 | 72292 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 1996 | 2642 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1986 | 295 | 0.010 |
Why?
|
| Craniopharyngioma | 1 | 1986 | 276 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2017 | 41464 | 0.010 |
Why?
|
| Rhabdomyosarcoma | 1 | 1986 | 358 | 0.010 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2009 | 928 | 0.010 |
Why?
|
| Infusions, Intravenous | 2 | 1999 | 2214 | 0.010 |
Why?
|
| Birefringence | 1 | 2003 | 54 | 0.010 |
Why?
|
| Electromagnetic Fields | 1 | 2005 | 289 | 0.010 |
Why?
|
| Proteins | 1 | 2017 | 6030 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2009 | 2897 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1991 | 6339 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2003 | 441 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12448 | 0.010 |
Why?
|
| Continuity of Patient Care | 1 | 2009 | 1067 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 1993 | 2056 | 0.010 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2003 | 191 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 1834 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1987 | 921 | 0.010 |
Why?
|
| Spinal Diseases | 1 | 2006 | 561 | 0.010 |
Why?
|
| Anesthesia, Local | 1 | 2003 | 277 | 0.010 |
Why?
|
| Synapses | 1 | 2010 | 1754 | 0.010 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2003 | 251 | 0.010 |
Why?
|
| Biological Availability | 1 | 2001 | 389 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2017 | 7847 | 0.010 |
Why?
|
| Life Expectancy | 1 | 1986 | 1242 | 0.010 |
Why?
|
| Brain Neoplasms | 2 | 1998 | 9026 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2001 | 560 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2004 | 2340 | 0.010 |
Why?
|
| Maximum Tolerated Dose | 1 | 2001 | 883 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 13635 | 0.010 |
Why?
|
| Age of Onset | 1 | 2005 | 3303 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 2001 | 335 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1987 | 2188 | 0.010 |
Why?
|
| Haplotypes | 1 | 2004 | 2713 | 0.010 |
Why?
|
| Atrophy | 1 | 2003 | 1632 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 2004 | 1047 | 0.010 |
Why?
|
| Head Injuries, Closed | 1 | 1999 | 133 | 0.010 |
Why?
|
| Facial Paralysis | 1 | 2002 | 346 | 0.010 |
Why?
|
| Craniocerebral Trauma | 2 | 1994 | 490 | 0.010 |
Why?
|
| Phenotype | 2 | 2004 | 16572 | 0.010 |
Why?
|
| Disease Progression | 2 | 2008 | 13495 | 0.010 |
Why?
|
| Fibrosis | 1 | 2004 | 2047 | 0.010 |
Why?
|
| Reoperation | 1 | 1987 | 4300 | 0.010 |
Why?
|
| Cochlea | 1 | 2003 | 844 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1997 | 364 | 0.010 |
Why?
|
| Pain | 1 | 1991 | 5062 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 4539 | 0.010 |
Why?
|
| Cryptococcus neoformans | 1 | 1997 | 120 | 0.010 |
Why?
|
| Fingers | 1 | 1999 | 506 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1986 | 3769 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2002 | 941 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1991 | 8473 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2851 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 1999 | 763 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 2413 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6074 | 0.010 |
Why?
|
| Body Temperature | 1 | 1998 | 780 | 0.010 |
Why?
|
| Flicker Fusion | 1 | 1994 | 14 | 0.010 |
Why?
|
| Diarrhea | 1 | 2001 | 1317 | 0.010 |
Why?
|
| Candida albicans | 1 | 1997 | 372 | 0.010 |
Why?
|
| Vestibular Function Tests | 1 | 1994 | 128 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2000 | 2256 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 1999 | 606 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2001 | 4010 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 6223 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1993 | 370 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1986 | 2894 | 0.010 |
Why?
|
| Neoplasms | 1 | 2001 | 22131 | 0.010 |
Why?
|
| Amines | 1 | 1993 | 281 | 0.010 |
Why?
|
| Color Perception Tests | 1 | 1991 | 12 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1994 | 915 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1997 | 1936 | 0.010 |
Why?
|
| Anthropometry | 1 | 1995 | 1338 | 0.010 |
Why?
|
| Gonioscopy | 1 | 1990 | 155 | 0.010 |
Why?
|
| Anterior Chamber | 1 | 1990 | 194 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10754 | 0.010 |
Why?
|
| Contrast Sensitivity | 1 | 1991 | 253 | 0.010 |
Why?
|
| Iris | 1 | 1990 | 232 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1994 | 1663 | 0.000 |
Why?
|
| Anticonvulsants | 1 | 1998 | 1910 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1992 | 13383 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11069 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 17878 | 0.000 |
Why?
|
| Indoles | 1 | 1993 | 1830 | 0.000 |
Why?
|
| Postoperative Period | 1 | 1990 | 1812 | 0.000 |
Why?
|
| Retinal Detachment | 1 | 1990 | 429 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2004 | 12116 | 0.000 |
Why?
|
| Survival Rate | 1 | 1998 | 12719 | 0.000 |
Why?
|
| Epilepsy | 1 | 1999 | 3303 | 0.000 |
Why?
|
| Laser Therapy | 1 | 1990 | 1093 | 0.000 |
Why?
|
| Laparoscopy | 1 | 1994 | 2030 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1994 | 5493 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1990 | 5965 | 0.000 |
Why?
|